Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease. |
| |
Authors: | Demetrius M Maraganore Matthew J Farrer Timothy G Lesnick Mariza de Andrade James H Bower Dena Hernandez John A Hardy Walter A Rocca |
| |
Affiliation: | Department of Neurology, Mayo Clinic, Rochester, Minnesota 55905, USA. dmaraganore@mayo.edu |
| |
Abstract: | We conducted a case-control study of the alpha-synuclein-interacting protein gene (SNCAIP, also known as synphilin-1) and Parkinson's disease (PD). A total of 319 PD cases and 195 controls were genotyped for four SNCAIP variants, including a microsatellite repeat in intron 4 and three restriction fragment length polymorphisms (RFLP) proximal to the 5' terminal of exons 1, 4, and 6. None of the variants were found associated with PD overall. Global score statistics were not significant for four, three, and two loci haplotypes. All four loci were in linkage disequilibrium for cases, controls, or both groups combined (P < 0.0001). Recursive partitioning showed no interactions between variants of the SNCAIP gene and variants of the alpha-synuclein gene (SNCA) or the parkin (PARK2) gene. |
| |
Keywords: | Parkinson's disease synphilin‐1 alpha‐synuclein parkin susceptibility genes association interactions |
|
|